Sam A. Eldessouky
2020
In 2020, Sam A. Eldessouky earned a total compensation of $1.3M as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International.
Compensation breakdown
| Non-Equity Incentive Plan | $225,000 |
|---|---|
| Option Awards | $187,631 |
| Salary | $500,000 |
| Stock Awards | $392,709 |
| Other | $12,825 |
| Total | $1,318,165 |
Eldessouky received $500K in salary, accounting for 38% of the total pay in 2020.
Eldessouky also received $225K in non-equity incentive plan, $187.6K in option awards, $392.7K in stock awards and $12.8K in other compensation.
Rankings
In 2020, Sam A. Eldessouky's compensation ranked 7,408th out of 13,090 executives tracked by ExecPay. In other words, Eldessouky earned more than 43.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,408 out of 13,090 | 43rd |
Division Manufacturing | 3,104 out of 5,617 | 45th |
Major group Chemicals And Allied Products | 1,251 out of 2,248 | 44th |
Industry group Drugs | 1,080 out of 1,948 | 45th |
Industry Pharmaceutical Preparations | 806 out of 1,453 | 45th |
Source: SEC filing on May 2, 2022.
Eldessouky's colleagues
We found four more compensation records of executives who worked with Sam A. Eldessouky at Valeant Pharmaceuticals International in 2020.
2020
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
2020
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
2020
Thomas Appio
Valeant Pharmaceuticals International
President Co, Head Bausch + Lomb/International
2020
Christina Ackermann
Valeant Pharmaceuticals International